Development and Biological Evaluation of Inkjet Printed Drug Coatings on Intravascular Stent.

Inkjet-printing technology was used to apply biodegradable and biocompatible polymeric coatings of poly(d,l-lactide) with the antiproliferative drugs simvastatin (SMV) and paclitaxel (PCX) on coronary metal stents. A piezoelectric dispenser applied coating patterns of very fine droplets (300 pL) and inkjet printing was optimized to develop uniform, accurate and reproducible coatings of high yields on the stent strut. The drug loaded polymeric coatings were assed by scanning electron microscopy (SEM), atomic force microscopy (AFM), and transition thermal microscopy (TTM) where a phase separation was observed for SMV/PLA layers while PCX showed a uniform distribution within the polymer layers. Cytocompatibility studies of PLA coatings showed excellent cell adhesion with no decrease of cell viability and proliferation. In vivo stent implantation studies showed significant intrastent restenosis (ISR) for PCX/PLA and PLA plain coatings similar to marketed Presillion (bare metal) and Cypher (drug eluting) stents. The investigation of several cytokine levels after 7 days of stent deployment showed no inflammatory response and hence no in vivo cytotoxicity related to PLA coatings. Inkjet printing can be employed as a robust coating technology for the development of drug eluting stents compared to the current conventional approaches.

[1]  A. Wagstaff,et al.  The Paclitaxel (TAXUS™)-Eluting Stent , 2004 .

[2]  M. Alexander,et al.  Inkjet printing as a novel medicine formulation technique. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[3]  K. Balss,et al.  Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal Raman and atomic force microscopy. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[4]  Dennis Douroumis,et al.  Inkjet printing of transdermal microneedles for the delivery of anticancer agents. , 2015, International journal of pharmaceutics.

[5]  Chi H. Lee,et al.  Advanced cardiovascular stent coated with nanofiber. , 2013, Molecular pharmaceutics.

[6]  Patrick W Serruys,et al.  Coronary stents: looking forward. , 2010, Journal of the American College of Cardiology.

[7]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[8]  Simon Wandel,et al.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.

[9]  M Kellomäki,et al.  Drug-eluting bioabsorbable stents - an in vitro study. , 2009, Acta biomaterialia.

[10]  A. Mikos,et al.  Osteoblast function on synthetic biodegradable polymers. , 1994, Journal of biomedical materials research.

[11]  Maria C. Dadarlat,et al.  Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine. , 2009, Molecular pharmaceutics.

[12]  W. J. van der Giessen,et al.  A practical and rapid method of histological processing for examination of coronary arteries containing metallic stents. , 1996, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[13]  Weng-Sing Hwang,et al.  Effects of Pulse Voltage on the Droplet Formation of Alcohol and Ethylene Glycol in a Piezoelectric Inkjet Printing Process with Bipolar Pulse , 2008 .

[14]  Giuseppe Perale,et al.  Bioresorbable polymer coated drug eluting stent: a model study. , 2012, Molecular pharmaceutics.

[15]  Minna Kellomäki,et al.  Drug-Eluting Biodegradable Poly-D/L-Lactic Acid Vascular Stents: An Experimental Pilot Study , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[16]  Sephra N. Rampersad,et al.  Multiple Applications of Alamar Blue as an Indicator of Metabolic Function and Cellular Health in Cell Viability Bioassays , 2012, Sensors.

[17]  R. Virmani,et al.  Endothelial cell recovery between comparator polymer-based drug-eluting stents. , 2008, Journal of the American College of Cardiology.

[18]  Ulrich S Schubert,et al.  Inkjet printing as a deposition and patterning tool for polymers and inorganic particles. , 2008, Soft matter.

[19]  L. Khachigian,et al.  A novel model of in-stent restenosis: rat aortic stenting , 2005, Heart.

[20]  C. Claussen,et al.  Thrombogenicity of various endovascular stent types: an in vitro evaluation. , 2002, Journal of vascular and interventional radiology : JVIR.

[21]  Abdul W. Basit,et al.  Preparation of Personalized-dose Salbutamol Sulphate Oral Films with Thermal Ink-Jet Printing , 2011, Pharmaceutical Research.

[22]  N. Turner,et al.  Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. , 2002, Journal of vascular surgery.

[23]  P. Serruys,et al.  The future of drug-eluting stents. , 2008, Pharmacological research.

[24]  B. Abella,et al.  Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis , 2001, Circulation.

[25]  R. Virmani,et al.  Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries , 2009, Circulation.

[26]  Celia N. Cruz,et al.  Application of Quality by Design (QbD) Approach to Ultrasonic Atomization Spray Coating of Drug-Eluting Stents , 2015, AAPS PharmSciTech.

[27]  Delia Radulescu,et al.  The Application of Ink-Jet Technology for the Coating and Loading of Drug-Eluting Stents , 2007, Annals of Biomedical Engineering.

[28]  H. Lehr,et al.  Generation of Human Pulmonary Microvascular Endothelial Cell Lines , 2001, Laboratory Investigation.

[29]  S. Logothetidis,et al.  Development of a nanoporous and multilayer drug-delivery platform for medical implants , 2012, International journal of nanomedicine.

[30]  E. Ribeiro,et al.  Randomized evaluation of two drug‐eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1‐Year results of the PAINT trial , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  D. M. Lynn,et al.  Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue. , 2013, Biomacromolecules.